Caribou Biosciences to Present at Upcoming Investor Conferences
March 07, 2022 16:11 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 07, 2022 16:05 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer
January 18, 2022 08:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the...
Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 16:05 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences to Present at Upcoming Investor Conferences
November 17, 2021 16:05 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results
November 09, 2021 16:05 ET
|
Caribou Biosciences, Inc.
On track to achieve key milestones, including plan to disclose initial clinical data in 2022 for lead product candidate CB-010 Expanded leadership with appointments of Ran Zheng and Dara...
Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer
November 08, 2021 09:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the...
Caribou Biosciences to Present at Upcoming Investor Conferences
October 20, 2021 16:00 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors
September 29, 2021 16:05 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today it has...
Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
September 27, 2021 16:05 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...